Skin Cancer News and Research

Latest Skin Cancer News and Research

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

Viewpoints: Texas and Florida should concentrate on uninsured; health law's costs to young adults being overlooked; obscure case could impact abortion issues

A new Census Bureau report documents the alarming percentages of people in Texas and Florida without health insurance. Leaders of both states should hang their heads in shame because they have been among the most resistant in the nation to providing coverage for the uninsured under the Affordable Care Act, the law that Republicans deride as "Obamacare" (9/4).

6 Sep 2013

Natural compound in broccoli helps reduce risk for skin cancer

With skin cancer emerging as one of the world's most prevalent forms of cancer, researchers are using every tool at their disposal to fight this disease. The tool of choice for Sally Dickinson, PhD? Broccoli.

5 Sep 2013

State highlights: At least 58 U.S. abortion clinics close after new, tighter laws; Minn. to end high-risk pool; Texas minors forbidden from tanning salons

At least 58 U.S. abortion clinics -- almost 1 in 10 -- have shut or stopped providing the procedure since 2011 as access vanishes faster than ever amid a Republican-led push to legislate the industry out of existence. A wave of regulations that makes it too expensive or logistically impossible for facilities to remain in business drove at least a third of the closings (Deprez, 9/3).

5 Sep 2013

First Edition: September 4, 2013

Todays headlines include reports about how the Balitmore Ravens will be part of the effort to raise public awareness about Maryland's health exchange.

4 Sep 2013

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

While it might be nice to pop a pill to protect your skin from the sun, a Loyola University Health System dermatologist warns that oral sunscreens are not as effective as traditional lotions and creams.

29 Aug 2013

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Vanderbilt has added genetic screening for the drug tacrolimus to its personalize medicine pharmacogenomics program PREDICT. The new drug screening protocol was added following data that shows a single genetic variation largely impacts different dose requirements for patients.

27 Aug 2013

Northwestern surgical oncologists use minimally invasive procedure to remove malignant melanoma

That's when she received the results from her dermatologist, who removed a part of the blister and had it tested. It turns out that little red bump was malignant melanoma, the leading cause of skin cancer death in the United States. It's a cancer that kills one person every hour, which translates to more than 8,700 Americans each year.

27 Aug 2013

Moffitt Cancer Center study could offer hope to melanoma sufferers

A new study at Moffitt Cancer Center could offer hope to people with melanoma, the deadliest form of skin cancer. Researchers are investigating whether an injectable known as PV-10 can shrink tumors and reduce the spread of cancer.

23 Aug 2013

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

A person's skin pigment, which determines hair color and skin tone, is influenced by the melanocortin-1 (MC1R) gene receptor. For the population's one to two percent of redheads, a mutation in MC1R accounts for their red hair color and typical light skin.

23 Aug 2013

Illinois prohibits minors under age of 18 from indoor tanning

Illinois has joined Vermont, California, Oregon, Nevada and Texas by passing legislation that prohibits minors under the age of 18 from indoor tanning. Following similar ordinances recently put in place in Springfield and Chicago, this law is based on significant scientific evidence that links indoor tanning to increased risk of developing melanoma and other forms of skin cancer.

19 Aug 2013

GHI research aims to target breast cancer stem-like cells using immunotherapy

New hope is on its way for the fight against breast cancer as Griffith Health Institute research aims to target the disease with immune-based therapies.

16 Aug 2013

Viewpoints: Health law's marketing challenge; GOP not to blame for implementation challenges

More than half of working-class whites say [the federal health law] is a bad idea. Perhaps most stunningly, so do 48% of those currently without health insurance - the very people who stand to gain the most, in the form of help finding and paying for coverage. Meanwhile, by a 30-point margin, political independents think they will be worse off under the law.

7 Aug 2013

Summer sun rays is one of the best treatments for psoriasis

Sun exposure is usually discouraged due to harmful rays causing skin cancer and premature aging but for the 7.5 million Americans suffering from psoriasis, the sun is a natural medication.

7 Aug 2013

Scientists discover way to target immune system to shrink tumors in mice

St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.

5 Aug 2013

Castle Biosciences to present DecisionDx-Melanoma test data at Summer Academy Meeting of AAD

Castle Biosciences Inc. announced that data from studies of its DecisionDx-Melanoma test are being presented today at the Summer Academy Meeting of the American Academy of Dermatology. The validation data confirm previous studies showing that the gene expression profile test is a strong independent predictor for classifying which Stage I or II non-metastatic cutaneous melanoma patients will likely recur.

2 Aug 2013

Keeping Alzheimer's disease in check

The future is looking good for drugs designed to combat Alzheimer's disease. EPFL scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease. Their research suggests that these compounds target the disease-causing peptides with high precision and with minimal side-effects.

2 Aug 2013

Skin Cancer News and Research

Latest Skin Cancer News and Research

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

Viewpoints: Texas and Florida should concentrate on uninsured; health law's costs to young adults being overlooked; obscure case could impact abortion issues

Natural compound in broccoli helps reduce risk for skin cancer

State highlights: At least 58 U.S. abortion clinics close after new, tighter laws; Minn. to end high-risk pool; Texas minors forbidden from tanning salons

First Edition: September 4, 2013

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Northwestern surgical oncologists use minimally invasive procedure to remove malignant melanoma

Moffitt Cancer Center study could offer hope to melanoma sufferers

MC1R mutation responsible for red hair phenotype also promotes cancer-causing pathway

Illinois prohibits minors under age of 18 from indoor tanning

GHI research aims to target breast cancer stem-like cells using immunotherapy

Viewpoints: Health law's marketing challenge; GOP not to blame for implementation challenges

Summer sun rays is one of the best treatments for psoriasis

Scientists discover way to target immune system to shrink tumors in mice

Castle Biosciences to present DecisionDx-Melanoma test data at Summer Academy Meeting of AAD

Keeping Alzheimer's disease in check

Omega-3 fatty acids can be used for treatment, prevention of skin and oral cancers: Research

Visual images of skin cancer most effective in prompting skin self-examinations

Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Skin Cancer News and Research

Latest Skin Cancer News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in